迪瑞医疗收盘下跌14.45%，滚动市盈率24.11倍，总市值34.22亿元

Group 1 - The core viewpoint of the news highlights that Dirui Medical's stock price has dropped significantly, with a closing price of 12.55 yuan, down 14.45%, and a rolling PE ratio of 24.11 times, indicating a lower valuation compared to the industry average [1] - Dirui Medical's total market capitalization is reported at 3.422 billion yuan, ranking 62nd in the medical device industry, which has an average PE ratio of 43.33 times and a median of 27.80 times [1][2] - The company experienced a net inflow of main funds amounting to 2.1455 million yuan on April 7, but overall, there has been a net outflow of 23.374 million yuan over the past five days [1] Group 2 - Dirui Medical specializes in the research, production, marketing, and service of medical testing instruments and related reagents, with key products including urine analysis, biochemical analysis, chemiluminescent immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory series [1] - The company holds a total of 213 patents, including 136 invention patents and 96 software copyrights [1] - For the latest fiscal year 2024, Dirui Medical reported an operating income of 1.218 billion yuan, a year-on-year decrease of 11.63%, and a net profit of 142 million yuan, down 48.50%, with a gross profit margin of 43.84% [1]